Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

CEFOXITIN Drug Profile

« Back to Dashboard

Which patents cover Cefoxitin, and what generic alternatives are available?

Cefoxitin is a drug marketed by Fresenius Kabi Usa, Hospira Inc, Acs Dobfar, Hikma Farmaceutica, West-ward Pharms Int, Acs Dobfar Spa, B Braun, and Samson Medcl. and is included in fourteen NDAs.

The generic ingredient in CEFOXITIN is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.

Summary for Tradename: CEFOXITIN

Suppliers / Packagers: see list7
Bulk Api Vendors: see list33
Clinical Trials: see list4
Patent Applications: see list4,694
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFOXITIN at DailyMed

Pharmacology for Tradename: CEFOXITIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
cefoxitin sodium
INJECTABLE;INJECTION065011-001Jul 3, 2000DISCNNoNo► Subscribe► Subscribe
Acs Dobfar Spa
cefoxitin sodium
INJECTABLE;INJECTION065467-002Aug 31, 2011APRXNoNo► Subscribe► Subscribe
Acs Dobfar
cefoxitin sodium
INJECTABLE;INJECTION065414-001Jun 12, 2009APRXNoYes► Subscribe► Subscribe
Hospira Inc
cefoxitin sodium
INJECTABLE;INJECTION065312-001Feb 13, 2006APRXNoNo► Subscribe► Subscribe
Hikma Farmaceutica
cefoxitin sodium
INJECTABLE;INJECTION065239-001Mar 2, 2010APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus